Clinical trials
Active, not recruiting Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
325 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 10 |
| 2017 | 15 |
| 2018 | 19 |
| 2019 | 29 |
| 2020 | 38 |
| 2021 | 39 |
| 2022 | 45 |
| 2023 | 39 |
| 2024 | 48 |
| 2025 | 15 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 325 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 27 |
| National Cancer Institute (NCI) | 27 |
| Memorial Sloan Kettering Cancer Center | 12 |
| AstraZeneca | 10 |
| City of Hope Medical Center | 8 |
| H. Lee Moffitt Cancer Center and Research Institute | 5 |
| Jonsson Comprehensive Cancer Center | 5 |
| SWOG Cancer Research Network | 5 |
| Abramson Cancer Center at Penn Medicine | 4 |
| Novartis Pharmaceuticals | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 325 |
| Carcinoma, Non-Small-Cell Lung | 127 |
| Breast Neoplasms | 37 |
| Neoplasms | 31 |
| Colorectal Neoplasms | 28 |
| Ovarian Neoplasms | 22 |
| Neoplasm Metastasis | 21 |
| Melanoma | 19 |
| Pancreatic Neoplasms | 19 |
| Small Cell Lung Carcinoma | 18 |
Trials
Showing 51 to 75 of 325. Each trial links to its page on Pharma Observatory.
225 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.